Pharmacological management of human respiratory syncytial virus infection

AM Kalergis, JA Soto, NMS Gálvez… - Expert Opinion on …, 2020 - Taylor & Francis
Introduction Human respiratory syncytial virus (hRSV) is the primary viral cause of
respiratory diseases, leading to bronchiolitis and pneumonia in vulnerable populations. The …

Pharmacological management of human respiratory syncytial virus infection

AM Kalergis, JA Soto, NMS Gálvez… - Expert opinion on …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction Human respiratory syncytial virus (hRSV) is the primary viral cause of
respiratory diseases, leading to bronchiolitis and pneumonia in vulnerable populations. The …

Pharmacological management of human respiratory syncytial virus infection

AM Kalergis, JA Soto, NMS Gálvez… - Expert Opinion on …, 2020 - researchers.unab.cl
Introduction: Human respiratory syncytial virus (hRSV) is the primary viral cause of
respiratory diseases, leading to bronchiolitis and pneumonia in vulnerable populations. The …

Pharmacological management of human respiratory syncytial virus infection.

AM Kalergis, JA Soto, NMS Gálvez… - Expert Opinion on …, 2020 - europepmc.org
Human respiratory syncytial virus (hRSV) is the primary viral cause of respiratory diseases,
leading to bronchiolitis and pneumonia in vulnerable populations. The only current …

Pharmacological management of human respiratory syncytial virus infection

AM Kalergis, JA Soto, NMS Gálvez… - Expert Opinion on …, 2020 - researchers.unab.cl
Introduction: Human respiratory syncytial virus (hRSV) is the primary viral cause of
respiratory diseases, leading to bronchiolitis and pneumonia in vulnerable populations. The …

[引用][C] Pharmacological management of human respiratory syncytial virus infection

AM Kalergis, JA Soto, NMS Gálvez, CA Andrade… - 2020

[引用][C] Pharmacological management of human respiratory syncytial virus infection

AM Kalergis, JA Soto, NMS Gálvez, CA Andrade… - 2020